References
- Chauhan BC, Mikelberg FS, Balaszi AG, et al. Canadian Glaucoma Study: 2. Risk factors for the progression of open-angle glaucoma. Arch Ophthalmol 2008;126:1030–1036
- Coleman AL, Miglior S. Risk factors for glaucoma onset and progression. Surv Ophthalmol 2008;53(Suppl. 1):S3–10
- Rossi GC, Pasinetti GM, Scudeller L, et al. Do adherence rates and glaucomatous visual field progression correlate? Eur J Ophthalmol 2011;21:410–414
- Vrijens B, De Geest S, Hughes DA, et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol 2012;73:691–705
- Ung C, Zhang E, Alfaro T, et al. Glaucoma severity and medication adherence in a county hospital population. Ophthalmology 2013;120:1150–1157
- Friedman DS, Quigley HA, Gelb L, et al. Using pharmacy claims data to study adherence to glaucoma medications: methodology and findings of the Glaucoma Adherence and Persistency Study (GAPS). Invest Ophthalmol Vis Sci 2007;48:5052–5057
- Dreer LE, Girkin C, Mansberger SL. Determinants of medication adherence to topical glaucoma therapy. J Glaucoma 2012;21:234–240
- Hermann MM, Bron AM, Creuzot-Garcher CP, et al. Measurement of adherence to brimonidine therapy for glaucoma using electronic monitoring. J Glaucoma 2011;20:502–508
- Tsai JC. A comprehensive perspective on patient adherence to topical glaucoma therapy. Ophthalmology 2009;116(11 Suppl.):S30–36
- Friedman DS, Okeke CO, Jampel HD, et al. Risk factors for poor adherence to eyedrops in electronically monitored patients with glaucoma. Ophthalmology 2009;116:1097–1105
- Okeke CO, Quigley HA, Jampel HD, et al. Adherence with topical glaucoma medication monitored electronically the Travatan Dosing Aid study. Ophthalmology 2009;116:191–199
- Wilensky J, Fiscella RG, Carlson AM, et al. Measurement of persistence and adherence to regimens of IOP-lowering glaucoma medications using pharmacy claims data. Am J Ophthalmol 2006;141(1 Suppl.):S28–33
- Nordstrom BL, Friedman DS, Mozaffari E, et al. Persistence and adherence with topical glaucoma therapy. Am J Ophthalmol 2005;140:598–606
- Djafari F, Lesk MR, Harasymowycz PJ, et al. Determinants of adherence to glaucoma medical therapy in a long-term patient population. J Glaucoma 2009;18:238–243
- Waterman H, Evans JR, Gray TA, et al. Interventions for improving adherence to ocular hypotensive therapy. Cochrane Database Syst Rev 2013;4:CD006132
- Newman-Casey PA, Weizer JS, Heisler M, et al. Systematic review of educational interventions to improve glaucoma medication adherence. Sem Ophthalmol 2013;28:191–201
- Cate H, Bhattacharya D, Clark A, et al. Patterns of adherence behaviour for patients with glaucoma. Eye (Lond) 2013;27:545–553
- Glanz K, Beck AD, Bundy L, et al. Impact of a health communication intervention to improve glaucoma treatment adherence. Results of the interactive study to increase glaucoma adherence to treatment trial. Arch Ophthalmol 2012;130:1252–1258
- Lim MC, Watnik MR, Imson KR, et al. Adherence to glaucoma medication: the effect of interventions and association with personality type. J Glaucoma 2013;22:439–446
- Barker GT, Cook PF, Schmiege SJ, et al. Psychometric properties of the Glaucoma Treatment Compliance Assessment Tool in a Multicenter Trial. Am J Ophthalmol 2015;159:1092–1099
- Chi YC, Wu CL, Chen CY, et al. Randomized trial of a secondhand smoke exposure reduction intervention among hospital-based pregnant women. Addictive Behav 2015;41:117–123
- Odeny TA, Bukusi EA, Cohen CR, et al. Texting improves testing: a randomized trial of two-way SMS to increase postpartum prevention of mother-to-child transmission retention and infant HIV testing. Aids 2014;28:2307–2312
- Boutron I, Moher D, Altman DG, et al. Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med 2008;148:295–309
- Rylander NR, Vold SD. Cost analysis of glaucoma medications. Am J Ophthalmol 2008;145:106–113
- CNIB (Canadian National Institute for the Blind). The cost of vision loss in Canada: Full Report. Toronto, 2009
- Okeke CO, Quigley HA, Jampel HD, et al. Interventions improve poor adherence with once daily glaucoma medications in electronically monitored patients. Ophthalmology 2009;116:2286–2293
- Gray TA, Fenerty C, Harper R, et al. Individualised patient care as an adjunct to standard care for promoting adherence to ocular hypotensive therapy: an exploratory randomised controlled trial. Eye (Lond) 2012;26:407–417
- Muir KW, Ventura A, Stinnett SS, et al. The influence of health literacy level on an educational intervention to improve glaucoma medication adherence. Patient Educ Counsel 2012;87:160–164
- Norell SE. Improving medication compliance: a randomised clinical trial. Br Med J 1979;2(6197):1031–1033
- Sheppard J, Warner J, Kelley K. An evaluation of the effectiveness of a nurse-led glaucoma monitoring clinic. Ophthalmic Nurs Int J Ophthalmic Nurs 2003;7:15–21
- Richardson C, Brunton L, Olleveant N, et al. A study to assess the feasibility of undertaking a randomized controlled trial of adherence with eye drops in glaucoma patients. Patient Pref Adher 2013;7:1025–1039
- Dupont WD, Plummer WD. Power and sample size calculations: a review and computer program. Controlled Clin Trials 1990;11:116–128